Conference Coverage (Lancet Conference)

Lifelong TB Prophylaxis May be Needed in Endemic Areas

Published in AIDS Weekly, October 9th, 1995

The value of fixed-duration tuberculosis preventive therapy may be limited in developing areas where TB is endemic, according to an official with the World Health Organization (WHO).

Richard O'Brien of WHO's Global TB Program said this is certainly the case with regard to HIV positive persons in developing countries with dual infection.

"Giving life-long isoniazid preventive therapy just makes sense," O'Brien said in a presentation delivered at The Lancet Conference 1995, "The Challenge of Tuberculosis," held in Washington D.C., September 14 and 15.

"I'm not sure this requires a clinical study. It seems to me to be fairly...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1995-10-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry